← Back to Search

Optimize Sleep (OS) for Sleep

N/A
Waitlist Available
Led By Chantelle N Hart, PhD
Research Sponsored by Temple University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline in mvpa at 6 months
Awards & highlights

Study Summary

This trial will evaluate if enhancing sleep, either alone or along with other activities that impact self-regulatory pathways related to sleep, can help prevent obesity in children.

Eligible Conditions
  • Sleep
  • Obesity

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline bmiz at 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline bmiz at 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in BMIz
Secondary outcome measures
Change in Blood Glucose Levels
Change in Body Composition
Change in Caloric Intake
+8 more

Trial Design

2Treatment groups
Active Control
Group I: Optimize Sleep (OS)Active Control1 Intervention
Optimize Sleep will focus exclusively on enhancing sleep by using effective behavioral strategies. Specific strategies to be used include: goal setting and self-monitoring, positive bedtime routines, stimulus control/sleep hygiene strategies, problem-solving regarding challenges, and review of effective strategies for relapse prevention.
Group II: Optimize Sleep-Plus (OS-Plus)Active Control1 Intervention
OS-Plus will focus on enhancing sleep and targeted eating (decreasing sugar-sweetened beverages and sweet and salty snack foods) and activity (increasing physical activity and decreasing TV viewing) behaviors. Specific strategies to be used include: goal setting and self-monitoring, positive bedtime routines, stimulus control/sleep hygiene strategies, problem-solving regarding challenges, and review of effective strategies for relapse prevention.

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,696 Previous Clinical Trials
6,952,439 Total Patients Enrolled
5 Trials studying Sleep
1,020 Patients Enrolled for Sleep
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,833 Previous Clinical Trials
47,306,347 Total Patients Enrolled
31 Trials studying Sleep
56,924 Patients Enrolled for Sleep
Temple UniversityLead Sponsor
296 Previous Clinical Trials
82,646 Total Patients Enrolled
5 Trials studying Sleep
596 Patients Enrolled for Sleep

Media Library

Optimize Sleep (OS) Clinical Trial Eligibility Overview. Trial Name: NCT03186508 — N/A
Sleep Research Study Groups: Optimize Sleep (OS), Optimize Sleep-Plus (OS-Plus)
Sleep Clinical Trial 2023: Optimize Sleep (OS) Highlights & Side Effects. Trial Name: NCT03186508 — N/A
Optimize Sleep (OS) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03186508 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experimental procedure open to elderly people aged 85 and above?

"Patients between the ages of 6 and 11 are eligible for enrollment in this clinical trial."

Answered by AI

What is the current number of participants in this research endeavor?

"Yes, the official documentation on clinicaltrials.gov affirms that this investigation, which first began recruiting participants on March 1st 2018, is still underway. A total of 204 individuals are being sought from a single location."

Answered by AI

Are there any vacancies in this clinical trial for interested participants?

"The details of the trial, posted on clinicaltrials.gov, demonstrate that it is currently inviting participants to take part. The project was initially displayed on March 1st 2018 and has most recently been updated April 25th 2022."

Answered by AI

Are my criteria satisfactory for me to partake in this trial?

"This medical trial is looking for 204 volunteers aged between 6 and 11 who are classified as obese. Additionally, the primary caregiver must be over 18 years old, with a BMI that falls within 25th percentile (but no greater than overweight) and they need to have an understanding of the protocol involved in this study. Furthermore, participants should express willingness to adhere to either treatment condition and enjoy food used during eating regulation paradigms."

Answered by AI
~21 spots leftby Apr 2025